Eli Lilly (LLY) Assets (2009 - 2026)
Eli Lilly (LLY) recorded Assets of $142.28 billion in Q2 2026, up 41.0% from $100.92 billion a year earlier and up 22.1% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly reported Assets of $112.48 billion, up 42.9% from FY2024.
- Annual Assets has increased for six straight years, with a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $78.72 billion in FY2024 (+23.0%), $64.01 billion in FY2023 (+29.3%), $49.49 billion in FY2022 (+1.4%) and $48.81 billion in FY2021 (+4.7%).
- The Q2 2026 figure is the highest quarterly Assets in data going back to Q2 2009.
- On a year-over-year basis, Assets has increased for 15 consecutive quarters, with growth averaging 37.5% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 52.0% in Q3 2025, against a decline of 1.6% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $116.58 billion (Q1 2026), $112.48 billion (Q4 2025) and $114.94 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,129.91 Bn | 1,098.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 613.69 Bn | 532.22 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 503.05 Bn | 476.16 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 367.72 Bn | 322.10 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.30 Bn | 234.99 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.86 Bn | 191.25 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.51 Bn | 164.71 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.83 Bn | 116.48 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Vertex Pharmaceuticals | 131.23 Bn | 103.23 Bn | 2.84 Bn | 27.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.28 Bn |
| Mar 31, 2026 | 116.58 Bn |
| Dec 31, 2025 | 112.48 Bn |
| Sep 30, 2025 | 114.94 Bn |
| Jun 30, 2025 | 100.92 Bn |
| Mar 31, 2025 | 89.39 Bn |
| Dec 31, 2024 | 78.72 Bn |
| Sep 30, 2024 | 75.61 Bn |
| Jun 30, 2024 | 71.87 Bn |
| Mar 31, 2024 | 63.94 Bn |
| Dec 31, 2023 | 64.01 Bn |
| Sep 30, 2023 | 57.92 Bn |
| Jun 30, 2023 | 54.81 Bn |
| Mar 31, 2023 | 53.16 Bn |
| Dec 31, 2022 | 49.49 Bn |
| Sep 30, 2022 | 47.46 Bn |
| Jun 30, 2022 | 47.06 Bn |
| Mar 31, 2022 | 46.92 Bn |
| Dec 31, 2021 | 48.81 Bn |
| Sep 30, 2021 | 48.19 Bn |
API Access
Eli Lilly Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();